EVE Health Group to Raise Capital via Share Placement and Large Option Issue

EVE Health Group Limited ( (AU:EVE) ) has provided an update.

EVE Health Group Limited has announced a proposed capital raising via a placement, planning to issue 47,450,000 new ordinary fully paid shares on the ASX. The issuance is scheduled for 19 March 2026, indicating the company’s intention to strengthen its balance sheet and support ongoing corporate or operational initiatives.

Alongside the shares, EVE plans to issue 90,400,000 options exercisable at A$0.04 expiring two years from issue and a further 5,000,000 options at the same exercise price expiring in three years. The large option component signals an effort to incentivise investors and potentially secure future capital inflows, which could dilute existing shareholders but provide funding flexibility if the share price appreciates above the exercise level.

The most recent analyst rating on (AU:EVE) stock is a Sell with a A$0.02 price target. To see the full list of analyst forecasts on EVE Health Group Limited stock, see the AU:EVE Stock Forecast page.

More about EVE Health Group Limited

EVE Health Group Limited is an Australian-listed company on the ASX under the code EVE. The group operates in the health sector, though the release focuses primarily on its capital markets activity rather than detailing specific products or services, suggesting an early-stage or capital-intensive growth profile.

Average Trading Volume: 317,040

Technical Sentiment Signal: Sell

Current Market Cap: A$5.98M

See more data about EVE stock on TipRanks’ Stock Analysis page.